<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04125043</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00011173</org_study_id>
    <nct_id>NCT04125043</nct_id>
  </id_info>
  <brief_title>Pediatric Red Reflex Study</brief_title>
  <official_title>Sensitivity and Specificity of the Red Reflex Test for Detecting Anterior and Posterior Segment Ophthalmic Pathology in the Pediatric Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's National Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's National Research Institute</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our Pediatric Red Reflex Study is designed to investigate the sensitivity and specificity of
      the Red Reflex Test (RRT), with and without dilation, for early detection of ocular
      abnormalities in children and newborns. The RRT functions by shining a light from an
      ophthalmoscope into a patient's eye and noting the presence or absence of a red glow. Despite
      its use in pediatric clinics for years, this test at times fails to detect significant ocular
      diseases, especially located in the back of the eye, threatening visual development in this
      population. Therefore, we aim to quantify the utility of this test as a tool for screening by
      comparing our findings on RRT with those of retinal photography.

      We hypothesize that the sensitivity and specificity of the RRT will be sufficient for
      detecting anterior segment pathology but will be insufficient for detecting posterior segment
      pathology with or without dilation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and Specificity of RRT</measure>
    <time_frame>1 year</time_frame>
    <description>sensitivity and specificity of the RRT in detecting anterior segment pathology, as well as the sensitivity and specificity of the RRT in detecting posterior segment pathology</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and Specificity of RRT with Dilation</measure>
    <time_frame>1 year</time_frame>
    <description>the sensitivity and specificity of the RRT in detecting anterior segment or posterior segmented pathology following pharmacologic dilation</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Abnormal Vitreous Humor Morphology</condition>
  <condition>Abnormal Choroid Morphology</condition>
  <condition>Optic Nerve Diseases</condition>
  <condition>Retinal Disease</condition>
  <condition>Retinal Hemorrhage</condition>
  <arm_group>
    <arm_group_label>RRT Group</arm_group_label>
    <description>Pediatric patients undergoing ocular screening tests</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Direct ophthalmoscope</intervention_name>
    <description>Red reflex test</description>
    <arm_group_label>RRT Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric patients under 17 years old recruited in clinical practice with known anterior or
        posterior segment pathology as well as patients without anterior or posterior segment
        pathology.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pediatric patients recruited in clinical practice with known anterior or posterior
             segment pathology as well as patients without anterior or posterior segment pathology

        Exclusion Criteria:

          -  Patients who have a history of disease, treatments and/or surgical procedures
             affecting the ability for normal pupillary reaction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>William Madigan, MD</last_name>
    <phone>202-476-3015</phone>
    <email>WMadigan@childrensnational.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jana Bregman</last_name>
    <phone>202-476-3015</phone>
    <email>jbregman@childrensnational.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's National Medical Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Bregman, MD</last_name>
      <phone>202-476-3015</phone>
      <email>jbregman@childrensnational.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 10, 2019</study_first_submitted>
  <study_first_submitted_qc>October 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2019</study_first_posted>
  <last_update_submitted>October 10, 2019</last_update_submitted>
  <last_update_submitted_qc>October 10, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Red reflex</keyword>
  <keyword>Posterior ocular abnormalities</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Optic Nerve Diseases</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
    <mesh_term>Retinal Hemorrhage</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>September 16, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT04125043/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

